Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to demonstrate, under clinical conditions, the effectiveness of the standard product 'Nutridrink' enriched with a mixture of plant extracts rich in polyphenolic compounds in the aspect of supporting the recovery of oncology patients undergoing surgical resection of tumours.


Clinical Trial Description

Oncology patients undergoing the procedure are exposed to various postoperative complications. Nutridrink with a mixture of extracts with anti-inflammatory and antioxidative properties aims to provide the patient with essential nutrients and bioactive substances that can reduce the inflammatory state, protect cells from oxidative damage, and decrease the risk of complications while supporting tissue healing processes after the surgical procedure. The study group are oncology patients undergoing surgical resection of gastrointestinal tumour. During the study, the effects of the mixture on levels of oxidative stress and inflammation markers will be assessed, as well as the subjective evaluation of patients' quality of life and well-being after surgical surgical tumor resection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06017661
Study type Interventional
Source AronPharma Sp. z o. o.
Contact
Status Recruiting
Phase N/A
Start date September 1, 2023
Completion date December 15, 2023

See also
  Status Clinical Trial Phase
Completed NCT05222347 - Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19
Completed NCT06218225 - Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections N/A
Completed NCT01736696 - Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis Phase 1
Completed NCT03107663 - ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma Phase 1
Recruiting NCT04375176 - Monocytes and NK Cells Activity in Covid-19 Patients